Get started
Author

Louise Andersen Lynggård

Observed names: Louise A Lynggård, Louise A. Lynggård, Louise Andersen Lynggaard
ORCID: 0000-0001-6026-5463
Observed ORCID: 0000-0001-6026-5463
OpenAlex ID: A5035899300
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study
2022 · Amber Louw, Vasiliki Panou, et al. · Journal of Thoracic Oncology · 70
PDF
Diagnostic capacity of BAP1 and MTAP in cytology from effusions and biopsy in mesothelioma
2022 · Louise Andersen Lynggård, Vasiliki Panou, et al. · Journal of the American Society of Cytopathology · 20
PDF
Carcinoid syndrome caused by a serotonin-secreting pituitary tumour
2013 · Louise A Lynggård, Eigil Husted Nielsen, et al. · European Journal of Endocrinology · 7
Managing the Expected, Diagnosing the Unexpected: A Rare Presentation of Undiagnosed Breast Carcinoma-A Case Report
2024 · Stine Marie Dalsborg Madsen, Louise Andersen Lynggård, et al. · Journal of Urological Surgery
PDF
Erdheim-Chester Disease in a 48-Year-Old Woman With “an Unknown Tumor of the Heart”: An Autopsy Report
2022 · Louise A. Lynggård, Martin Agge Nørgaard, et al. · AJSP Review and Reports
PDF
Works count: 5
Citation count: 97
H-index: 3
I10-index: 2
Year
Topic
Type